CHEMICAL/BIOLOGICAL DEFENSE (ATD)
Abstract
The projects in this program element (PE) demonstrate technologies supporting transition to advanced component development for physical capabilities which cover biological and chemical detection, situational awareness and effects modeling, and protection and hazard mitigation. Other major efforts support enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for early warning in pathogen detection and diagnosis, and pretreatments and therapeutics against a broader set of chemical and biological agents. Medical capabilities (pretreatments, therapeutics, diagnostics capabilities, and drug manufacturing and regulatory science technologies), include capabilities against non-traditional agents. Individual projects include: - Chemical Biological Defense (CB3): demonstrations of CB physical science defense technologies, including biological detection, chemical detection, digital battlespace management, and protection, and decontamination. The Project continues to pursue solutions against traditional agents. - NTA Defense (NT3): dedicated research (both medical and non-medical) is consolidated in NT3. This effort includes NTA chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. - Medical Defense (TM3): aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. - Technology Transition (TT3): pursues federal R&D or commercially available products to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack. The CBDP S&T Advanced Technology Development stakeholders: United States Army Edgewood Chemical Biological Center (ECBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. This PE is dedicated to conducting proof-of-principle field demonstrations, and testing system-specific technologies to meet specific military needs. Work conducted under this PE will transition to and will provide risk reduction for PE 0603884BP and PE 0604384BP activities.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2020
- Source ID
- 0603384BP_3_0400_PB_2020
- Change Summary Explanation
- Funding: FY18 (-$0.974M): Reprogramming adjustments to balance overall portfolio efforts. FY18 (-$3.143M): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY20 (+$31.400M): Increase for Medical Countermeausures Initiative and CBDP Support to Bio-Incident Response. FY20 (-$9.082M): Funds transfered to BA2 - Threat Agent Science portfolio to expand threat characterization and assessments to minimize surprise from emerging and advanced CBRN threats Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (ATD)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Percutaneous Protection
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Biosurveillance (BSV)
- Child Accomplishment: 6) Detection
- Child Accomplishment: 7) Hazard Prediction
- Child Accomplishment: 8) Hazard Prediction
- Child Accomplishment: 9) Data Analysis
- Child Accomplishment: 10) Data Analysis
- Child Accomplishment: 11) Operational Effects
- Child Accomplishment: 12) Operational Effects
- Child Accomplishment: 13) Decision Analysis and Management
- Child Accomplishment: 14) Threat Surveillance
- Child Accomplishment: 15) Warning and Reporting
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (ATD)
- Child Accomplishment: 1) Material Contamination Mitigation
- Child Accomplishment: 2) Personnel Contamination Mitigation
- Child Accomplishment: 3) Respiratory and Ocular Protection
- Child Accomplishment: 4) Therapeutics - Medical
- Child Accomplishment: 5) Detection
- Child Accomplishment: 6) Modeling & Simulation
- Child Accomplishment: 7) Percutaneous Protection
- Child Accomplishment: 8) Test & Evaluation
- Child Accomplishment: 9) Pretreatments and Prophylactics - Medical
- Child Project: TECHBASE MED DEFENSE (ATD)
- Child Accomplishment: 1) Assays and Reagents
- Child Accomplishment: 2) Bacterial Therapeutics
- Child Accomplishment: 3) Bacterial/Toxin Vaccines
- Child Accomplishment: 4) Biosurveillance (BSV)
- Child Accomplishment: 5) Diagnostic Device Platforms
- Child Accomplishment: 6) Medical Countermeasures Initiative
- Child Accomplishment: 7) Vaccine Platforms and Research Tools
- Child Accomplishment: 8) Viral Therapeutics
- Child Accomplishment: 9) Viral Vaccines
- Child Accomplishment: 10) Medical Diagnostics
- Child Accomplishment: 11) Chemical Therapeutics
- Child Accomplishment: 12) Medical Diagnostics Response Capability Development
- Child Project: TECHBASE TECHNOLOGY TRANSITION
- Child Accomplishment: 1) Experiment & Technology Demonstrations